Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis

Roberto R. Giraldez1 José Carlos Nicolau2 Ramon Corbalan3 Enrique P. Gurfinkel4 Ursulo Juarez5 Jose Lopez-Sendon6 Alexander Parkhomenko7 Peter Molhoek8 Satishkumar Mohanavelu1 David A. Morrow1 and Elliott M. Antman1

首页> 外文期刊>European Heart Journal >Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis

【24h】

Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis

机译：无论溶血栓的选择如何，对于接受纤维蛋白溶解的ST抬高型心肌梗死患者，依诺肝素优于普通肝素：ExTRACT-TIMI 25分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Aims We compared outcomes of ST-elevation myocardial infarction (STEMI) patients randomized to a strategy of either enoxaparin or unfractionated heparin (UFH) to support fibrinolysis.

机译：目的我们比较了随机分为依诺肝素或普通肝素（UFH）策略支持纤维蛋白溶解的ST段抬高型心肌梗死（STEMI）患者的结局。

著录项

来源
《European Heart Journal》 |2007年第13期|1566-1573|共8页
作者
Roberto R. Giraldez1 José Carlos Nicolau2 Ramon Corbalan3 Enrique P. Gurfinkel4 Ursulo Juarez5 Jose Lopez-Sendon6 Alexander Parkhomenko7 Peter Molhoek8 Satishkumar Mohanavelu1 David A. Morrow1 and Elliott M. Antman1;
展开▼
作者单位

TIMI Study Group Cardiovascular Division Department of Medicine Brigham and Women's Hospital Harvard Medical School 350 Longwood Avenue 1st Floor Boston MA 02115 USA;

Heart Institute (InCor) University of Sao Paulo Medical School Sao Paulo Brazil;

Department of Cardiovascular Diseases Pontificia Universidad Catolica Santiago Chile;

Fundacion Favaloro Buenos Aires Argentina;

Coronary Care Unit Instituto Nacional de Cardiologia Ignacio Chavez Mexico City Mexico;

H. Gregorio Maranon Madrid Spain;

Institute of Cardiology Kiev Ukraine;

Enschede The Netherlands;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trial. [J] . Morrow DA, Antman EM, Fox KA, European Heart Journal: The Journal of the European Society of Cardiology . 2010,第17期

机译：在针对ST段抬高型心肌梗死行纤维蛋白溶解的患者中，使用依诺肝素和普通肝素策略后的一年结果：ExTRACT-TIMI 25试验的1年结果。
2. One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 Trial [J] . David A. Morrow, Elliott M. Antman, Keith A.A. Fox, European Heart Journal . 2010,第17期

机译：在针对ST段抬高型心肌梗死行纤维蛋白溶解的患者中，使用依诺肝素与普通肝素策略后的一年结果：ExTRACT-TIMI 25试验的1年结果
3. Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25 [J] . Harvey D. White1 Eugene Braunwald2 Sabina A. Murphy2 Ashok J. Jacob3 Nina Gotcheva4 Leonid Polonetsky5 and Elliott M. Antman2 European Heart Journal . 2007,第9期

机译：依诺肝素与普通肝素联合纤溶治疗老年和年轻患者ST段抬高型心肌梗死：ExTRACT-TIMI 25的结果
4. Feasibility and Predictors of Mortality of Transradial Approach in Elderly Patients with ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Angioplasty [C] . Jimenez Diaz VA, Baz Alonso JA, De Miguel Castro A, International Congress on Coronary Artery Disease . 2011

机译：老年人急性心肌梗死老年患者跨越患者颅脑癌患者死亡率的可行性和预测因素
5. Meta-analysis: The impact of thrombectomy during PCI (percutaneous coronary intervention) on mortality, re-infarction and target vessel revascularization among patients with ST elevation myocardial infarction compared with standard PCI. [D] . Martar, Martar. 2016

机译：荟萃分析：与标准PCI相比，ST抬高型心肌梗死患者在PCI（经皮冠状动脉介入治疗）期间进行血栓切除术对死亡率，再梗塞和靶血管血运重建的影响。
6. Cost-effectiveness of enoxaparin compared with unfractionated heparin in ST elevation myocardial infarction patients undergoing pharmacological reperfusion: A Canadian analysis of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment – Thrombolysis in Myocardial Infarction (ExTRACT-TIMI) 25 trial [O] . Robert C Welsh, Luc Sauriol, Zugui Zhang, 2009

机译：在接受药理学再灌注的ST抬高型心肌梗死患者中依诺肝素与普通肝素相比的成本效益：加拿大对依诺肝素和溶栓再灌注治疗急性心肌梗死的加拿大分析-心肌梗塞溶栓（ExTRACT-TIMI）25试验
7. Cost-effectiveness of enoxaparin compared with unfractionated heparin in ST elevation myocardial infarction patients undergoing pharmacological reperfusion: A Canadian analysis of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment – Thrombolysis in Myocardial Infarction (ExTRACT-TIMI) 25 trial [O] . Welsh, Robert C, Sauriol, Luc, Zhang, Zugui, 2009

机译：在接受药理学再灌注的ST抬高型心肌梗死患者中依诺肝素与普通肝素相比的成本-效果：依诺肝素和溶栓再灌注治疗急性心肌梗死的加拿大分析-心肌梗塞溶栓（ExTRACT-TIMI）25试验

Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅